Clinical Trial Update: Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis [Phase 4]

View source ↗

Summary

A Phase 4 trial of endovenous corticosteroid pulses in moderate ulcerative colitis was terminated. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SOLU-MEDROL (Methylprednisolone sodium succinate)

Snippet

Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | Conditions: Ulcerative Colitis | Phase 4 | Status: TERMINATED | Results posted: 2025-02-21